期刊文献+

青春期乳房肥大症乳腺组织中雌激素受体的表达 被引量:8

Expression of the estrogen receptor in the glandular tissue of the pubertal mammary hypertrophy
下载PDF
导出
摘要 目的:探讨雌激素受体(ER)在青春期乳房肥大症乳腺组织中的表达及意义。方法:应用免疫组化SP法检测了18例青春期乳房肥大症及12例原发性小乳症乳腺组织中ER的表达情况。结果:ER在青春期乳房肥大症和原发性小乳症乳腺组织中的阳性表达率分别为88.89%和16.67%,两者比较差异有统计学意义(P<0.01)。结论:青春期乳房肥大症的发生可能与乳腺组织中ER的表达增加有关。 Objective To investigate the expression of the estrogen receptor(ER) and its significance in pubertal mammary hypertrophy.Methods The expression of ER was detected by SP immunohistochemistry in 18 cases of pubertal mammary hypertrophy and 12 cases of micromastia.Results The positive expression rate of ER was respectively 88.89% and 16.67% in pubertal mammary hypertrophy and micromastia.There was significant difference between the two groups(P<0.01).Conclusion The pubertal mammary hypertrophy may be related to the excessive expression of ER within breast tissue.
出处 《中国美容医学》 CAS 2007年第2期156-158,共3页 Chinese Journal of Aesthetic Medicine
关键词 青春期 乳房肥大症 雌激素受体 puberty mammary hypertrophy estrogen receptor
  • 相关文献

参考文献12

  • 1郭树忠,鲁开化,艾玉峰,韩岩.乳房缩小成形术手术方法的选择与比较[J].中国美容医学,2001,10(3):220-222. 被引量:15
  • 2[2]Stmad P,Zavadil M,Danes J,et al.The importance of hormone receptors in benign breast diseases[J].Ceska Gynekol,1998,63(1):29-38.
  • 3[3]Gion M,Mione R,Dittadi R,et al.Estrogen and progesterone receptors in breast carcinoma and in nonmalignant breast tissue[J].Tumori,1985,71(5):477-481.
  • 4[4]Silva JS,Georgiade GS,Dilley WG,et al.Menstrual cycle-dependent variations of breast cyst fluid proteins and sex steroid receptors in the normal human breast[J].Cancer,1983,51(7):1297-1302.
  • 5[5]Jabs AD,Frantz AG,Smith-Vaniz A,et al.Mammary hypertrophy is not associated with increased estrogen receptors[J].Plast Reconstr Surg,1990,86(1):64-66.
  • 6[6]Morimoto T,Komaki K,Mori T,et al.Juvenile gigantomastia:report of a case[J].Surg Today,1993,23(3):260-264.
  • 7[7]Noczynska A,Wasikowa R,Myczkowski T.Hypersensitivity of estrogen receptors as a cause of gigantomasty in two girls[J].Pol Merkuriusz Lek,2001,11(66):507-509.
  • 8秦映芬,沈寒蕾,黄松,韦敏怡.巨乳症的临床与病理学观察[J].临床与实验病理学杂志,2004,20(3):292-294. 被引量:14
  • 9孙家明,乔群,戚可名.肥大乳房和小乳房乳腺组织中雌激素受体的表达[J].中华整形外科杂志,2004,20(6):415-417. 被引量:14
  • 10[10]Baker SB,Burkey BA,Thornton P,et al.Juvenile gigantomastia:presentation of four cases and review of the literature[J].Ann Plast Surg,2001,46(5):517-525.

二级参考文献24

  • 1胡伯年,傅燕萍,车张云,李忠麟,董传昌,黄黎明,高原,叶春辉,王伟.乳腺增生症针穿细胞雌激素受体和孕激素受体测定及三苯氧胺治疗的研究[J].医师进修杂志,1994,17(11):32-33. 被引量:2
  • 2[1]Robbins, T. H. A reduction mammoplasty with the areola-nipple based on an inferior dermal pedicle [J] Plast. Reconstr. Surg, 1977;59
  • 3[2]Mckissock, P. K. Reduction mammoplasty [J] Ann. Plast.Surg, 1997; 2:321
  • 4[3]Marchac, D, and de Olarte, G. Reduction mammoplasty and correction of ptosis with a short inframammary scar [J] Plast. Reconstr. Surg, 1982; 69:45
  • 5[4]Scott L. and John W. Little, Ⅲ. Reduction mammoplasty and Mastopexy [M] Grabb and Smith's Plastic Surgery. Fifth Edition,Lippincott. 1997:725
  • 6曹月敏. 乳腺外科学. 郑州:河南科学技术出版社,1991:115.
  • 7Cruz-Korchin N, Korchin L, Gonzalez-Keelan C, et al. Macromastia: how much of it is fat? Plast Reconstr Surg, 2002,109(1):64~8.
  • 8Arscott GD,Craig HR,Gabay L. Failure of bromocriptine therapy to control juvenile mammary hypertrophy. Br J Plast Surg, 2001,54(8):720~3.
  • 9Jabs AD, Frantz AG, Smith-Vaniz A, et al. Mammary hypertrophy is not associated with increased estrogen receptors. Plast Reconstr Surg, 1990,86(1):64~6.
  • 10Morimoto T, Komaki K, Mori T, et al. Juvenile gigantomastia: report of a case. Surg Today, 1993,23(3):260~4.

共引文献30

同被引文献74

  • 1秦映芬,沈寒蕾,黄松,韦敏怡.巨乳症的临床与病理学观察[J].临床与实验病理学杂志,2004,20(3):292-294. 被引量:14
  • 2孙家明,乔群,戚可名.肥大乳房和小乳房乳腺组织中雌激素受体的表达[J].中华整形外科杂志,2004,20(6):415-417. 被引量:14
  • 3刘民,陈织,李辉,张海华,王惠玲.双环法缩乳技术的改进[J].中国美容医学,2007,16(1):45-46. 被引量:15
  • 4徐鹰妮,姜军,程鸿,凡庆东,谢竞,周艳,唐鹏.ERα和ERβ在不同类型乳腺组织的表达及其意义[J].第三军医大学学报,2007,29(11):1093-1095. 被引量:12
  • 5Androutsopoulos G, Adonakis G, Gkermpesi M, et al. Expression of the epidermal growth factor system in endometrial cancer after adjuvant tamoxifen treatment for breast cancer. [J]. Eur J Gynaecol Oncol, 2006, 27(5): 490-494.
  • 6Tommaso Simoncini, Elena Rabkin, James K. Molecular basis of cell membrane estrogen receptor interaction with phosphatidylinositol 3-Kinase in endothelial cells[J]. Arterioseler Thromb Vasc Biol, 2003, 23(2): 198-203.
  • 7Yue W, Wang JP, Hamilton CJ, et al. In situ aromatization enhances breast tumor estradiol levels and cellular proliferation. Cancer Res, 1998,58(5) :927-932.
  • 8Lu Q, Nakmura J, Savinov A, et al. Expression of aromatase protein and messenger ribonucleic acid in tumor epithelial cells and evidence of functional significance of locally produced estrogen in human breast cancers. Endocrinology, 1996, 137(7):3061-3068.
  • 9Peterson OW, Hoyer PE, van Duurs B. Frequency and distribution of estrogen receptor positive ceils in normal, non-lactating human breast tissue. Cancer Res, 1987,47 (21) : 5748-5751.
  • 10Leygue ER, Watson PH, Murphy LC. Estrogen receptor variants in normal human mammary tissue. J Natl Cancer Inst, 1996,88(5) : 284-290.

引证文献8

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部